|
|
|
Volumn 1, Issue 3, 2005, Pages 209-215
|
|
Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BERAPROST;
DRUG DERIVATIVE;
ENDOTHELIAL NITRIC OXIDE SYNTHASE;
FENOFIBRATE;
NOS3 PROTEIN, HUMAN;
PROSTACYCLIN;
UNCLASSIFIED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
VASODILATOR AGENT;
ATHEROSCLEROSIS;
BLOOD PRESSURE;
DIABETIC ANGIOPATHY;
DRUG COMBINATION;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HUMAN;
LIPID METABOLISM;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
REVIEW;
VASCULAR ENDOTHELIUM;
VASODILATATION;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
ATHEROSCLEROSIS;
BLOOD GLUCOSE;
BLOOD PRESSURE;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DRUG THERAPY, COMBINATION;
ENDOTHELIUM, VASCULAR;
EPOPROSTENOL;
HUMANS;
HYPOGLYCEMIC AGENTS;
LIPID METABOLISM;
NITRIC OXIDE SYNTHASE TYPE III;
PROCETOFEN;
VASCULAR CELL ADHESION MOLECULE-1;
VASODILATION;
VASODILATOR AGENTS;
|
|
EID: 33947518835
PISSN: 11766344
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (15)
|
|
References (60)
|
